Sera Prognostics Inc (SERA)
2.29
+1.78%
Sera Prognostics Inc (SERA) is currently trading at $2.29. This represents a gain of 1.78% from the previous session. With a market capitalization of $0.09B, SERA is a key component of the Health Care sector. Investors looking to trade SERA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade SERA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Sera Prognostics Inc (SERA) shows a bullish trend. Analysts are watching the 2.50 level closely.
Fundamentals
Mkt Cap0.09B
P/E Ratio0.0000
Volume61,727
60-Day Technical Chart
Advanced Charting
Need more indicators for SERA? Use the world's #1 platform.
Open SERA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
SERA +1.78% |
CCO +1.05% |
CLOV +3.98% |
UIS +15.49% |
|---|---|---|---|---|
| Price | $2.29 | $2.40 | $2.09 | $2.46 |
| Mkt Cap | $0.09B | $1.20B | $1.08B | $0.18B |
| - | View → | View → | View → |
Latest Headlines
Insider Sell: Robert Harrison Sells 2,000 Shares of Sera Prognos
GuruFocus • Feb 25, 2026
Sera Prognostics (NASDAQ:SERA) Stock Price Down 2.3% - Here's Why
MarketBeat • Feb 21, 2026
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
PR Newswire • Nov 13, 2025
Lung disease drug helps sicker patients walk farther but misses main trial goal
Stock Titan • Feb 23, 2026
Have Insiders Sold Sera Prognostics Shares Recently?
simplywall.st • Dec 13, 2025
● Gemini Agentic AI Analyst Insight for SERA
Market Education
- Canadian ETF Uptrend Pivot Dec 10, 2023
- The Animal Trading Playbook Sep 8, 2025
- The Basics of the Stock Market for Beginners Aug 25, 2023
External Research